Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials

OBJECTIVES: The aim of this integrated analysis is to evaluate the long-term safety and tolerability of ixekizumab in adults with psoriasis, PsA and axial SpA. METHODS: Integrated safety data from 21 clinical trials are presented by indication in patients who received at least one dose of ixekizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Genovese, Mark C, Mysler, Eduardo, Tomita, Tetsuya, Papp, Kim A, Salvarani, Carlo, Schwartzman, Sergio, Gallo, Gaia, Patel, Himanshu, Lisse, Jeffrey R, Kronbergs, Andris, Leage, Soyi Liu, Adams, David H, Xu, Wen, Marzo-Ortega, Helena, Lebwohl, Mark G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733711/
https://www.ncbi.nlm.nih.gov/pubmed/32449924
http://dx.doi.org/10.1093/rheumatology/keaa189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733711/
https://www.ncbi.nlm.nih.gov/pubmed/32449924
http://dx.doi.org/10.1093/rheumatology/keaa189

Ejemplares similares